Policy, Identity, and Neurotechnology

Veljko Dubljević, Ph.D., D.Phil., is a University Faculty Scholar and Associate Professor of Philosophy and Science, Technology & Society at NC State University, and leads the NeuroComputational Ethics Research Group. He is a recipient of a NSF CAREER award, and has published extensively in neuroethics, neurophilosophy and ethics of AI. Allen Coin, MA, works as a Web Strategist at NC State University, where he is also an Associate Member of the NeuroComputational Ethics Research Group. He currently holds a master's degree focused on Science, Technology, and Society (STS) and his research interests are in the ethical and societal implications of emerging technologies, particularly neurotechnology and AI. Under the guidance of Dr. Dubljević, Coin has published a number of papers on BCIs as the lead author.

1. An Introduction to Policy, Identity, and Neurotechnology: The Neuroethics of Brain-Computer Interfaces.- Part 1: The Past, Present, and Future of BCI Technology.- 2. Posthuman subjectivity in BCI-VR entanglement.- 3. "The trauma of losing your own identity again": The Ethics of Explantation of Brain-Computer Interfaces.- 4. Ethical Considerations of Endovascular Brain-Computer Interfaces.- 5. Future Developments in Brain/Neural-Computer Interface Technology.- 6. A Path to Science Fiction Style Technology Applications? The Example of Brain-to-Brain Interfaces.- Part 2: Ethical and Philosophical Issues.- 7. A Scoping Review of the Academic Literature on BCI Ethics.- 8. "HAVING THE ABILITY TO HAVE A GOOD LIFE: What might be the impact of BCIs?".- 9. Cyborg Virtues: Using Brain Stimulation for Moral Enhancement.- 10. Brain Co-Processors: Ethical and Social Implications.- Part 3: Legal and Policy Implications.- 11. United States Policy on BCIs: Funding Research, Regulating Therapies, and Commercializing Consumer Technology.- 12. "Memory Enhancement and Brain Computer Interface Devices: Technological Possibilities and Constitutional Challenges".- 13. Cyberneurosecurity.- 14. Perspectives of Current FDA Guidance on BCI Technology.- 15. Neurotechnology, Stakeholders, & Neuroethics: Real Decisions and Tradeoffs from an Insider's Perspective.